BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Nuvilex's Medical Marijuana Sciences Prepares to Enhance Industry's Research With Cell-in-a-Box™


1/15/2014 8:38:23 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

NEW YORK, NY--(Marketwired - January 14, 2014) - While Nuvilex, Inc. (OTCQB: NVLX) continues to lay the foundation for its medical marijuana subsidiary, Medical Marijuana Sciences, Inc. (MMS), a growing list of studies continue to prove that Cannabis is having a dramatic effect on different types of cancer. Executives at MMS are preparing to enter the medical marijuana industry with a very different approach. Some of the company's work will be based on the live-cell encapsulation technology Nuvilex owns the rights to use with regard to any and all types of cancer.

As Nuvilex and MMS COO Dr. Gerald Crabtree has said, it is the company's intent to be a leader in the industry, and to use its expertise in the biotechnology space to drive research that lends to the marijuana debate. He said, "MMS plans to develop treatments, which employ constituents of Cannabis together with the Cell-in-a-Box™ cellulose-based live-cell encapsulation technology, for some of the deadliest forms of cancer."

Patients in search of what potential answers could come from using constituents of Cannabis together with the cell encapsulation technology, need look no further than what has been accomplished with Cell-in-a-Box™ in both pancreatic cancer clinical trials and diabetes studies. Now MMS could use that same approach to bolster research being done in glioblastoma multiforme (GBM), a type of brain cancer highly resistant to current anticancer treatments.

It is crucial to find new therapeutic strategies aimed at improving the poor prognosis of patients suffering from this disease, and MMS may be able to address this deadly cancer using the Cell-in-a-Box™ technology.

Nuvilex is currently into its preparations for late-phase clinical trials in advanced, inoperable pancreatic cancer using Cell-in-a-Box™, and these trials will only add to the experience the company's executives will have using this technology. Given the solid team they're putting together at MMS, they will likely use that experience to enhance the medical marijuana industry's search for cures to many types of cancer.

About Stock Market Media Group
SMMG is a full service IR firm specializing in Research and Content Development. It offers a platform for corporate stories to unfold through the media with Reports, Interviews and Articles. For more information and to read disclaimers and disclosures: www.stockmarketmediagroup.com.


Contact:
Stock Market Media Group
Email Contact

Digg this    Bookmark with del.icio.us    Add to Newsvine

Technorati:



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

Nuvilex
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES